Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Nektar Therapeutics - 30 Year Stock Price History | NKTR

Historical daily share price chart and data for Nektar Therapeutics since 1994 adjusted for splits and dividends. The latest closing stock price for Nektar Therapeutics as of April 23, 2024 is 1.42.
  • The all-time high Nektar Therapeutics stock closing price was 108.44 on March 08, 2018.
  • The Nektar Therapeutics 52-week high stock price is 1.75, which is 23.2% above the current share price.
  • The Nektar Therapeutics 52-week low stock price is 0.41, which is 71.1% below the current share price.
  • The average Nektar Therapeutics stock price for the last 52 weeks is 0.67.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Nektar Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 0.8327 0.5948 1.6700 0.4936 1.4200 151.33%
2023 0.9654 2.1900 3.1500 0.4227 0.5650 -75.00%
2022 5.2973 13.6600 13.7200 2.0300 2.2600 -83.27%
2021 17.3794 17.6600 25.4600 10.8300 13.5100 -20.53%
2020 19.8952 20.9600 27.9600 14.4700 17.0000 -21.24%
2019 29.0393 34.2200 46.3500 15.8700 21.5850 -34.33%
2018 64.8573 57.6500 108.4400 30.4300 32.8700 -44.96%
2017 23.6689 12.6900 60.5000 11.7500 59.7200 386.72%
2016 14.6323 16.2000 19.6800 11.0000 12.2700 -27.18%
2015 12.6614 15.1650 17.4100 9.5000 16.8500 8.71%
2014 13.0060 11.8700 17.0500 10.5300 15.5000 36.56%
2013 10.6668 7.5400 13.9600 7.5400 11.3500 53.17%
2012 7.8108 5.7600 10.8300 5.6800 7.4100 32.44%
2011 7.5754 12.5300 12.5300 4.2200 5.5950 -56.46%
2010 13.4286 9.6800 15.8800 9.3900 12.8500 37.88%
2009 6.9010 5.7900 10.4700 4.0300 9.3200 67.63%
2008 5.0190 6.6000 7.5000 2.8300 5.5600 -17.14%
2007 9.9415 15.2400 15.2400 5.2200 6.7100 -55.88%
2006 17.8389 16.4400 22.7500 13.1000 15.2100 -7.59%
2005 16.7294 19.7600 19.8000 13.4100 16.4600 -18.68%
2004 17.5096 14.3000 23.2400 9.6900 20.2400 48.71%
2003 9.8080 8.5600 14.9410 4.4600 13.6100 68.44%
2002 8.7516 18.2200 18.2200 4.1300 8.0800 -56.44%
2001 22.9463 44.5000 48.2500 11.0100 18.5500 -63.27%
2000 43.1314 20.8450 63.3100 20.8450 50.5000 137.31%
1999 14.5148 17.0000 21.8450 11.5000 21.2800 28.97%
1998 14.1301 12.8450 17.1250 10.7500 16.5000 26.92%
1997 11.8156 7.6250 18.2500 7.6250 13.0000 71.96%
1996 7.5270 5.1250 10.3100 5.0000 7.5600 55.08%
1995 4.7988 4.5000 7.1900 3.5000 4.8750 5.41%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.261B $0.090B
Nektar Therapeutics is a biopharmaceutical company, focused on the development of treatments utilizing its PEGylation and advanced polymer conjugate technology platforms. Nektar primarily finances its operations with funds from licensing, collaboration and manufacturing agreements. It has collaboration deals with companies namely AstraZeneca, Pfizer, Roche, Amgen, Bristol-Myers and Eli Lilly among others. The company's most lucrative deal is with Bristol-Myers, which provided the company with significant cash resources to support progress of its pipeline and share development costs for its lead candidate, bempegaldesleukin. Nektar recognizes product sales from its manufacturing and supply agreements with several pharma companies related to products developed using its PEGylation platform. The company also earns royalty payments from the sales of products using its technology platforms. Amgen's neutropenia drug, Neulasta is one of the drugs developed using Nektar's PEGylation platform.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $68.403B 28.11
Chugai Pharmaceutical (CHGCY) Japan $55.239B 23.99
Takeda Pharmaceutical (TAK) Japan $42.345B 6.86
Merck (MKGAF) Germany $20.744B 19.57
Astellas Pharma (ALPMY) Japan $17.174B 24.33
Shionogi (SGIOY) Japan $14.546B 12.59
Sandoz Group AG (SDZNY) Switzerland $14.473B 0.00
Neurocrine Biosciences (NBIX) United States $13.940B 57.89
United Therapeutics (UTHR) United States $11.034B 11.82
Catalent (CTLT) United States $10.140B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.624B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.909B 7.01
Ionis Pharmaceuticals (IONS) United States $6.098B 0.00
Revolution Medicines (RVMD) United States $5.972B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.345B 0.00
Alpine Immune Sciences (ALPN) United States $4.231B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.078B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.946B 0.00
Evotec AG (EVO) Germany $2.711B 0.00
Summit Therapeutics (SMMT) United States $2.617B 0.00
Indivior (INDV) United States $2.569B 11.94
Corcept Therapeutics (CORT) United States $2.394B 24.21
Dyne Therapeutics (DYN) United States $2.192B 0.00
PTC Therapeutics (PTCT) United States $1.947B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.915B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.818B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.807B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.738B 17.96
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.658B 9.82
Avadel Pharmaceuticals (AVDL) Ireland $1.639B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.587B 27.78
Ardelyx (ARDX) United States $1.487B 0.00
Soleno Therapeutics (SLNO) United States $1.341B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.301B 12.22
4D Molecular Therapeutics (FDMT) United States $1.269B 0.00
Pacira BioSciences (PCRX) United States $1.247B 12.41
Collegium Pharmaceutical (COLL) United States $1.175B 7.23
Xencor (XNCR) United States $1.123B 0.00
Cronos Group (CRON) Canada $0.944B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.943B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.903B 0.00
Cassava Sciences (SAVA) United States $0.889B 0.00
USANA Health Sciences (USNA) United States $0.861B 13.56
ARS Pharmaceuticals (SPRY) United States $0.820B 0.00
Enliven Therapeutics (ELVN) United States $0.813B 0.00
Sage Therapeutics (SAGE) United States $0.778B 0.00
Relay Therapeutics (RLAY) United States $0.774B 0.00
Ocular Therapeutix (OCUL) United States $0.774B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.736B 0.00
Silence Therapeutics (SLN) United Kingdom $0.674B 0.00
Savara (SVRA) United States $0.648B 0.00
Siga Technologies (SIGA) United States $0.623B 9.22
Lyell Immunopharma (LYEL) United States $0.622B 0.00
ProKidney (PROK) United States $0.580B 0.00
Verve Therapeutics (VERV) United States $0.575B 0.00
Korro Bio (KRRO) United States $0.545B 0.00
OmniAb (OABI) United States $0.543B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.542B 0.00
Altimmune (ALT) United States $0.537B 0.00
Exscientia (EXAI) United Kingdom $0.529B 0.00
KalVista Pharmaceuticals (KALV) United States $0.473B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.448B 0.00
Heron Therapeutics (HRTX) United States $0.421B 0.00
Larimar Therapeutics (LRMR) United States $0.412B 0.00
Lexeo Therapeutics (LXEO) United States $0.400B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.397B 0.00
Esperion Therapeutics (ESPR) United States $0.396B 0.00
Organogenesis (ORGO) United States $0.393B 74.50
Tourmaline Bio (TRML) United States $0.387B 0.00
Nature's Sunshine Products (NATR) United States $0.372B 20.81
Harrow (HROW) United States $0.365B 0.00
Bioventus (BVS) United States $0.341B 0.00
Aquestive Therapeutics (AQST) United States $0.314B 0.00
Fractyl Health (GUTS) United States $0.314B 0.00
Lyra Therapeutics (LYRA) United States $0.311B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.291B 0.00
Akebia Therapeutics (AKBA) United States $0.287B 0.00
ESSA Pharma (EPIX) Canada $0.283B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.278B 0.00
Nanobiotix S.A (NBTX) France $0.269B 0.00
Metagenomi (MGX) United States $0.263B 0.00
Pyxis Oncology (PYXS) United States $0.262B 0.00
Black Diamond Therapeutics (BDTX) United States $0.259B 0.00
Adherex Technologies (FENC) United States $0.250B 0.00
Xeris Biopharma Holdings (XERS) United States $0.250B 0.00
Aldeyra Therapeutics (ALDX) United States $0.232B 0.00
Avita Medical (RCEL) United States $0.231B 0.00
Conduit Pharmaceuticals (CDT) United States $0.229B 0.00
Acrivon Therapeutics (ACRV) United States $0.222B 0.00
Foghorn Therapeutics (FHTX) United States $0.220B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Prelude Therapeutics (PRLD) United States $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.209B 0.00
Century Therapeutics (IPSC) United States $0.203B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.200B 0.00
Zevra Therapeutics (ZVRA) United States $0.199B 0.00
Profound Medical (PROF) Canada $0.188B 0.00
Telomir Pharmaceuticals (TELO) United States $0.172B 0.00
MediWound (MDWD) Israel $0.156B 0.00
Achieve Life Sciences (ACHV) Canada $0.154B 0.00
CytoDyn (CYDY) United States $0.149B 0.00
Regulus Therapeutics (RGLS) United States $0.148B 0.00
Incannex Healthcare (IXHL) Australia $0.145B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.132B 2.79
VAXART, INC (VXRT) United States $0.132B 0.00
Elite Pharmaceuticals (ELTP) United States $0.132B 12.32
Karyopharm Therapeutics (KPTI) United States $0.127B 0.00
Cardiol Therapeutics (CRDL) Canada $0.126B 0.00
Inotiv (NOTV) United States $0.125B 0.00
Citius Pharmaceuticals (CTXR) United States $0.122B 0.00
GlycoMimetics (GLYC) United States $0.118B 0.00
Relmada Therapeutics (RLMD) United States $0.118B 0.00
OptiNose (OPTN) United States $0.109B 0.00
FibroGen (FGEN) United States $0.106B 0.00
Eliem Therapeutics (ELYM) United States $0.104B 0.00
Vivani Medical (VANI) United States $0.099B 0.00
ProPhase Labs (PRPH) United States $0.093B 0.00
PMV Pharmaceuticals (PMVP) United States $0.093B 0.00
AlloVir (ALVR) United States $0.091B 0.00
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
Assertio Holdings (ASRT) United States $0.087B 7.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.085B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.079B 0.00
Tempest Therapeutics (TPST) United States $0.076B 0.00
Carisma Therapeutics (CARM) United States $0.071B 0.00
Journey Medical (DERM) United States $0.071B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Mural Oncology (MURA) Ireland $0.062B 0.00
SCYNEXIS (SCYX) United States $0.059B 0.87
Reneo Pharmaceuticals (RPHM) United States $0.056B 0.00
Gain Therapeutics (GANX) United States $0.055B 0.00
BioLineRx (BLRX) Israel $0.051B 0.00
Jaguar Animal Health (JAGX) United States $0.046B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.039B 0.00
JanOne (JAN) United States $0.039B 0.00
Natural Alternatives (NAII) United States $0.039B 0.00
Unicycive Therapeutics (UNCY) United States $0.037B 0.00
Protara Therapeutics (TARA) United States $0.034B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
CASI Pharmaceuticals (CASI) China $0.034B 0.00
Viracta Therapeutics (VIRX) United States $0.033B 0.00
VYNE Therapeutics (VYNE) United States $0.033B 0.00
NRx Pharmaceuticals (NRXP) United States $0.030B 0.00
Surrozen (SRZN) United States $0.029B 0.00
Nutriband (NTRB) United States $0.028B 0.00
DURECT (DRRX) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Oncternal Therapeutics (ONCT) United States $0.024B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 10.93
MEI Pharma (MEIP) United States $0.022B 1.12
TherapeuticsMD (TXMD) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.022B 0.00
Indaptus Therapeutics (INDP) United States $0.021B 0.00
CERo Therapeutics Holdings (CERO) United States $0.020B 0.00
Addex Therapeutics (ADXN) Switzerland $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Alaunos Therapeutics (TCRT) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Dominari Holdings (DOMH) United States $0.016B 0.00
Talphera (TLPH) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Traws Pharma (TRAW) United States $0.014B 0.00
Avalo Therapeutics (AVTX) United States $0.013B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.010B 0.00
Cosmos Health (COSM) Greece $0.009B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.006B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.29
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 43.90